Granted Patent
B2
US 8,003,641 · App. 11/796,200 · Granted Aug 23, 2011
Compositions and methods of treating cell proliferation disorders
Assignee:
Kinex Pharmaceuticals, LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to compounds and methods for treating cell proliferation disorders.
Claims (10)
1. A compound according to the formula
or a salt, tautomer or prodrug thereof.
2. The compound of claim 1 , wherein said compound is an acid addition salt.
3. A composition comprising a compound according to claim 1 and at least one pharmaceutically acceptable excipient.
4. A compound having the formula:
5. A composition comprising the compound
and at least one pharmaceutically acceptable excipient.
6. A pharmaceutically acceptable salt of a compound having the formula:
7. A composition comprising a pharmaceutically acceptable salt of a compound having the formula:
and at least one pharmaceutically acceptable excipient.
Assignments (9)
SECURITY INTEREST
Recorded Sep 16, 2022
From: ATHENEX, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 061119/0681 →
SECURITY INTEREST
Recorded Sep 16, 2022
From: ATNX SPV, LLC
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 061119/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 13, 2022
From: ATHENEX, INC.
To: ATNX SPV, LLC
Reel/Frame 061071/0086 →
SECURITY INTEREST
Recorded Jun 22, 2020
From: ATHENEX, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 053005/0657 →
RELEASE OF SECURITY INTEREST
Recorded Jun 19, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ATHENEX, INC.
Reel/Frame 052990/0677 →
PATENT SECURITY AGREEMENT
Recorded Jul 3, 2018
From: ATHENEX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047247/0812 →
CHANGE OF NAME
Recorded Sep 21, 2015
From: KINEX PHARMACEUTICALS, INC.
To: ATHENEX, INC.
Reel/Frame 036644/0296 →
CHANGE OF NAME
Recorded Sep 10, 2015
From: KINEX PHARMACEUTICALS, LLC
To: KINEX PHARMACEUTICALS, INC.
Reel/Frame 036585/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 22, 2011
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 025997/0092 →
Continuity (5)
Provisional Application
60639834
· Dec 28, 2004
Provisional Application
60704551
· Aug 1, 2005
Provisional Application
60727341
· Oct 17, 2005